Drug Discovery Product Showcase

11. Predict And Assign Fragment Ions 6/11/2026

    Model MS fragmentation pathways and align predictions with experimental data to assign fragment ions faster. Streamline spectral interpretation and confirm compound identities with greater confidence.

12. Robust Methods With Fewer Injections 6/11/2026

    A smarter approach to method selection helps labs reduce guesswork and maintain consistent results. Learn how structured workflows and guided optimization can support confident decisions.

13. Mass Spectrometry Software For Spectral Interpretation And Characterization 6/11/2026

    One MS Software for All Your Mass Spectral Data Analysis and Management

    ACD/MS Workbook Suite is an all-in-one package for MS data handling.

    • Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
    • Auto-annotate peaks and associate them with compound structures
    • Identify unknowns by deconvoluting spectra and searching databases for spectral matches
    • Create easily shareable and searchable spectral databases
14. Our Most Advanced MS Toolset For Structure Characterization 6/11/2026

    Characterize Samples and Identify Unknown Components

    Do you often need to identify unknown compounds from complex samples? ACD/MS Structure ID Suite offers a simple, replicable workflow for generating and narrowing down structural candidates.

    • Deconvolute complex LC/MS and GC/MS data into individual component traces
    • Search proprietary and commercial databases for spectral matches
    • Search PubChem for accurate-mass and molecular-formula matches
    • Narrow down candidate structures by retention time and fragment include/exclude lists
15. Predict MS Fragments For Your Compound 6/11/2026

    Rules-Based Fragment Prediction for Mass Spectrometry

    ACD/MS Fragmenter helps you predict mass spectral fragmentation in seconds. Have more confidence in your compound IDs, learn about fragmentation mechanisms, and publish your results easily.

    It’s as simple as this:

    • Draw your compound
    • Select the ionization polarity and fragmentation options
    • View its fragmentation tree
16. Develop Chromatographic Methods Faster With Prediction Software 6/11/2026

    Your Method Development Toolbox

    ACD/Method Selection Suite is your software assistant for LC and GC method development. When you want to develop methods using Quality by Design (QbD) principles, and make every experiment count, reach for Method Selection Suite to:

    • Choose your starting conditions and columns
    • Simulate separations under new conditions
    • Optimize your chromatography with 1D, 2D, or 3D models
    • Predict the retention times of new compounds
    • Database successful methods for future use
17. Metabolite Identification Software That Makes Decisions Easier 6/11/2026

    Understand Your Biotransformation Data

    MetaSense helps you make sense of all your metabolite identification (MetID) data. Move beyond complex workflows that have you flipping back and forth between a dozen programs.

    With a single interface for prediction, data analysis, and knowledge dashboards, make data-driven decisions swiftly.

    • Collect all your MetID data and view it in one place
    • Auto-generate biotransformation maps and kinetic plots
    • Click between interactively linked maps and plots to see your data at any depth
    • Reprocess data directly from MetaSense
    • Draw conclusions about a drug candidate’s metabolism and viability
18. Hybridoma Services 6/5/2026

    Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.

19. Phage And Yeast Display 6/5/2026

    Curia offers phage and eukaryotic-based yeast display platforms for in vitro discovery and engineering of potent antibody candidates for therapeutic or diagnostic use. High-affinity functional antibodies are routinely selected against a wide range of conventional or challenging targets (e.g. GPCRs) using customized or in-licensed state-of-the-art libraries.

20. Recombinant Antibody Production 6/5/2026

    Curia has extensive experience with constructing and producing antibodies in our mammalian platforms.